Key Takeaways
- • AlphaSimplex Group, an affiliate of Natixis Investment Managers, appointed Dr. Kathryn M. Kaminski as Chief Research Strategist effective May 1, 2018, creating a newly established position within the firm.
- • Dr. Kaminski joined from the MIT Laboratory for Financial Engineering, bringing over a decade of hands-on investment experience and recognized expertise in managed futures and alternative asset classes.
- • In her role, Dr. Kaminski will conduct applied research supporting AlphaSimplex products, serve as co-manager on the Managed Futures Strategy portfolio management team, and educate investors on alternatives integration—reporting directly to Chief Investment Officer David Modest, Ph.D.
- • Dr. Kaminski will manage two key managed futures funds: the Natixis ASG Managed Futures Strategy Fund (AMFAX) in the U.S. and The ASG Managed Futures Fund (ASGMSFA), a Luxembourg Sicav.
- • The appointment strengthens AlphaSimplex's research infrastructure and reflects the firm's strategic focus on alternatives and systematic investment strategies within its managed futures product suite.
Summary
AlphaSimplex Group, an investment manager affiliate of Natixis Investment Managers, has appointed Dr. Kathryn M. Kaminski to the newly created role of Chief Research Strategist, effective May 1, 2018. Dr. Kaminski joins the firm from the MIT Laboratory for Financial Engineering, where she developed expertise in quantitative research and systematic trading approaches.
In her new capacity, Dr. Kaminski will serve as co-manager on AlphaSimplex's Managed Futures Strategy portfolio management team and will oversee research initiatives supporting the firm's alternatives offerings. Her responsibilities include conducting applied research, developing strategic research initiatives, and educating institutional investors on the portfolio construction benefits of alternatives, particularly managed futures. She will report to Chief Investment Officer David Modest, Ph.D., and collaborate with Deputy Chief Investment Officer Alexander Healy, Ph.D., and portfolio managers including Peter Lee, Robert Sinnott, Philippe Luedi, Ph.D., Robert Rickard, David Kuenzi, John Perry, Ph.D., and Derek Schug.
Dr. Kaminski will manage two significant managed futures funds: the Natixis ASG Managed Futures Strategy Fund (AMFAX) in the United States and The ASG Managed Futures Fund (ASGMSFA), a Luxembourg Sicav structure. Her appointment reflects AlphaSimplex's commitment to enhancing its research depth in alternative strategies at a time when institutional investors increasingly seek diversification through managed futures and systematic investment approaches.
CEO Duncan Wilkinson emphasized that Dr. Kaminski's "considerable knowledge in managed futures strategies" and "over a decade of hands-on investment experience" would deliver tangible benefits to AlphaSimplex clients. Dr. Kaminski, who holds the Chartered Alternative Investment Analyst (CAIA) designation, expressed confidence in the firm's "accomplishments, investment philosophy and team," signaling strong cultural alignment with the organization's strategic direction.
In her new capacity, Dr. Kaminski will serve as co-manager on AlphaSimplex's Managed Futures Strategy portfolio management team and will oversee research initiatives supporting the firm's alternatives offerings. Her responsibilities include conducting applied research, developing strategic research initiatives, and educating institutional investors on the portfolio construction benefits of alternatives, particularly managed futures. She will report to Chief Investment Officer David Modest, Ph.D., and collaborate with Deputy Chief Investment Officer Alexander Healy, Ph.D., and portfolio managers including Peter Lee, Robert Sinnott, Philippe Luedi, Ph.D., Robert Rickard, David Kuenzi, John Perry, Ph.D., and Derek Schug.
Dr. Kaminski will manage two significant managed futures funds: the Natixis ASG Managed Futures Strategy Fund (AMFAX) in the United States and The ASG Managed Futures Fund (ASGMSFA), a Luxembourg Sicav structure. Her appointment reflects AlphaSimplex's commitment to enhancing its research depth in alternative strategies at a time when institutional investors increasingly seek diversification through managed futures and systematic investment approaches.
CEO Duncan Wilkinson emphasized that Dr. Kaminski's "considerable knowledge in managed futures strategies" and "over a decade of hands-on investment experience" would deliver tangible benefits to AlphaSimplex clients. Dr. Kaminski, who holds the Chartered Alternative Investment Analyst (CAIA) designation, expressed confidence in the firm's "accomplishments, investment philosophy and team," signaling strong cultural alignment with the organization's strategic direction.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.